Xoma | XOMA - Trade Creditors


Xoma reported $2.65M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 85.29M 10.89M Sep/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Ardelyx USD 18.39M 3.29M Sep/2025
aTyr Pharma USD 4.06M 184K Sep/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Celldex Therapeutics USD 1.18M 3.09M Dec/2025
Curis USD 4.1M 1.01M Jun/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Emergent BioSolutions USD 112.2M 500K Dec/2023
Incyte USD 1.63B 1.46B Dec/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Prothena USD 10.5M 1.7M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Xoma USD 2.65M 1.52M Sep/2025